Drug Trial Radar · NCT05202509
Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease
Last checked: Nov 19, 2026Latest source record: Jun 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
9,541
Actual
Start
Feb 7, 2022
Primary completion
Nov 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- NewAmsterdam PharmaIndustry
- Sponsor type
- Industry
- Collaborators
- Monash University
- First posted
- Jan 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD) who are not adequately controlled despite maximally tolerated lipid-lowering therapy.
Conditions
- Atherosclerotic Cardiovascular Disease
Interventions
ObicetrapibDrug
10mg obicetrapib tablet
PlaceboDrug
Placebo tablet to resemble obicetrapib
Primary outcomes
What the sponsor says the trial is designed to measure.
- Major Adverse Cardiovascular Effect (MACE)Time frame: 30 months after last participant randomized
Locations
591 sites in 23 countries. Site status is shown where the registry gives one.
Advanced Cardiovascular LLC
Alexander City, Alabama
Ascension - Cardiology Specialists of Birmingham
Birmingham, Alabama
Central Alabama Research
Birmingham, Alabama
Cardiovascular Associates of the Southeast, LLC
Birmingham, Alabama
Eastern Shore Research Institute, LLC
Fairhope, Alabama
The Heart Center Research
Huntsville, Alabama
Mobile Heart Specialists
Mobile, Alabama
Syed Research Consultants
Muscle Shoals, Alabama
Syed Research Consultants
Sheffield, Alabama
Elite Clinical Studies
Phoenix, Arizona
Clinical Research Institute of Arizona, LLC
Sun City West, Arizona
Eclipse Clinical Research
Tucson, Arizona
NEA Baptist clinic
Jonesboro, Arkansas
Cardiology and Medicine Clinic
Little Rock, Arkansas
Advanced Research Center
Anaheim, California
Westside Medical Associates of Los Angeles
Beverly Hills, California
Hope Clinical Research LLC
Canoga Park, California
Titan Medical Research - Oceanside
Encinitas, California
Clinical Trials Research
Lincoln, California
Torrance Clinical Research Institute Inc.
Lomita, California
American Institute of Research
Los Angeles, California
Amicis Research Center-Northridge
Northridge, California
Amicis Research
Northridge, California
Valley Clinical Trials, Inc
Northridge, California
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Torrance, California
Cardiology Associates of Fairfield County
Norwalk, Connecticut
Excel Medical Clinical Trials
Boca Raton, Florida
Clearwater Cardiovascular and Interventional Consultants
Clearwater, Florida
Innovative Research of West Florida
Clearwater, Florida
Avail Clinical Research
DeLand, Florida
Invesclinic
Fort Lauderdale, Florida
Qway Research
Hialeah, Florida
New Generation of Medical Research
Hialeah, Florida
East Coast Institute for Research
Jacksonville, Florida
East Coast Institute for Research - Jacksonville Monroe St
Jacksonville, Florida
East Coast Institute for Research - Jacksonville University Blvd
Jacksonville, Florida
East Coast Institute for Research - Perimeter Park Court
Jacksonville, Florida
East Coast Institute for Research- Lake City
Lake City, Florida
Columbus Clinical Services
Miami, Florida
Finlay Medical Research Corp
Miami, Florida
Showing 40 of 591 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.